The prevalence of factor v Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran

Molecular Biology Reports

Volumn 36, Issue 8, 2009, Pages 2361-2364

  Mozafari, Hadi ^a   Rahimi, Zohreh ^a,b,c   Heidarpour, Azadeh ^a   Fallahi, Mahsa ^a   Muniz, Adraiana ^d  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Factor V Leiden; G6PD deficiency; Iran; MTHFR C677T; Prothrombin G20210A

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HIND111 ENYZME; HINFF1 ENZYME; PROTHROMBIN; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; THROMBOPHILIA;

ADOLESCENT; FACTOR V; FEMALE; GENE FREQUENCY; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; IRAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MOLECULAR EPIDEMIOLOGY; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; YOUNG ADULT;

EID: 70350341972     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9458-x     Document Type: Article

References (23)

1. A Drousiotou EH Touma N Andreou J Loiselet M Angastiniotis BC Verrelli, et al. 2004 Molecular characterization of G6PD deficiency in Cyprus Blood Cells Mol Dis 33 25 30 10.1016/j.bcmd.2004.03.004 10.1016/j.bcmd.2004.03.004 1:CAS:528:DC%2BD2cXlt1egur8%3D 15223006 (Pubitemid 38829593)
2. Z Rahimi A Vaisi-Raygani RL Nagel A Muniz 2006 Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran Blood Cells Mol Dis 37 91 94 10.1016/j.bcmd.2006.07.004 10.1016/j.bcmd.2006.07.004 1:CAS:528:DC%2BD28XpvFSjsbk%3D 16938474 (Pubitemid 44416278)
3. G Endler C Mannhalter 2003 Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis Clin Chim Acta 330 31 55 10.1016/S0009-8981(03)00022-6 10.1016/S0009-8981(03)00022-6 1:CAS:528: DC%2BD3sXhvFWrtLo%3D 12636925 (Pubitemid 36287633)
4. SR Poort FR Rosendaal PH Reitsma RM Bertina 1996 A common genetic variation in the 3́-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698 3703 1:CAS:528:DyaK28XntVahsLg%3D 8916933
5. AP Walker 2005 Portal vein thrombosis: what is the role of genetics? Eur J Gastroenterol Hepatol 17 705 707 10.1097/01.meg.0000170927.60979.1d 10.1097/01.meg.0000170927.60979.1d 15947546 (Pubitemid 40896415)
6. GN Welch J Loscalzo 1998 Homocysteine and atherothrombosis N Engl J Med 338 1042 1050 10.1056/NEJM199804093381507 10.1056/NEJM199804093381507 1:CAS:528:DyaK1cXislaqtr4%3D 9535670 (Pubitemid 28180407)
7. Z Rahimi A Vaisi-Raygani H Kharrazi H Mozafari M Rezaei RL Nagel 2008 Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran J Thromb Thrombolysis 25 280 283 10.1007/s11239-007-0052-6 10.1007/s11239-007-0052-6 1:CAS:528: DC%2BD1cXmsVamurk%3D 17700999 (Pubitemid 351772731)
8. V Cikes I Abaza V Krzelj IM Terzic R Tafra A Trlaja, et al. 2004 Prevalence of factor V Leiden and G6PD 1311 silent mutations in Dalmatian population Arch Med Res 35 546 548 10.1016/j.arcmed.2004.07.005 10.1016/j.arcmed.2004.07.005 1:CAS:528:DC%2BD2MXnvFer 15631882 (Pubitemid 41043628)
9. Old JM, Higgs (1983) Gene analysis. In: Weatherall DJ (ed) Methods in hemotology. The thalassemias, vol 6. Churchill Livingstone, London, pp 74-101
10. E Beutler, et al. 1979 International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G6PD) deficiency Br J Haematol 43 465 467 10.1111/j.1365-2141.1979.tb03774.x 10.1111/j.1365-2141.1979.tb03774.x 1:CAS:528:DyaL3cXjs1Giuw%3D%3D 497122
11. SA Tishkoff R Varkonyi N Cahinhinan S Abbes G Argyropoulos G Destro-Bisol, et al. 2001 Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malaria resistance Science 293 455 462 10.1126/science.1061573 10.1126/science.1061573 1:CAS:528: DC%2BD3MXlsFemtL4%3D 11423617 (Pubitemid 32679066)
12. RM Bertina BPC Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde, et al. 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 64 67 10.1038/369064a0 10.1038/369064a0 1:CAS:528:DyaK2cXktVKnt7c%3D 8164741 (Pubitemid 24144355)
13. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews, et al. 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 111 113 10.1038/ng0595-111 10.1038/ng0595-111 1:CAS:528:DyaK2MXlsVymt78%3D 7647779
14. A Oppenheim CL Jury D Rund TJ Vulliamy L Luzzatto 1993 G6PD mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews Hum Genet 91 293 294 10.1007/BF00218277 10.1007/BF00218277 1:CAS:528:DyaK3sXkvFejtL0%3D 8478015
15. B Kurdi-Haidar PJ Mason A Berrebi G Ankra-Badu A al-Ali A Oppenheim, et al. 1990 Origin and spread of the glucose-6-phosphate variant (G6PD-Mediterranean) in the Middle East Am J Hum Genet 47 1013 1019 1:CAS:528:DyaK3MXit1ams70%3D 1978555
16. Y Mortazavi R Chopra EC Gordon-Smith TR Rurherford 1997 Frequency of G6PD nt 1311 C/T polymorphism in English and Iranian populations: relevance to studies of X chromosome inactivation J Med Genet 34 1028 1029 10.1136/jmg.34.12.1028 1:STN:280:DyaK1c%2FptVynug%3D%3D 9429150
17. J Sun Y Xu J Xue Y Zhu H Lu 2005 Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients Mol Cell Endocrinol 229 95 101 10.1016/j.mce.2004.09. 003 10.1016/j.mce.2004.09.003 1:CAS:528:DC%2BD2cXhtVyqs7jJ 15607533 (Pubitemid 40018087)
18. M Kawashiri K Kajinami A Nohara K Yagi A Inazu J Koizumi, et al. 2000 Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia Am J Cardiol 86 8 840 845 10.1016/S0002-9149(00)01103-6 10.1016/S0002-9149(00)01103-6 1:CAS:528: DC%2BD3cXnt1Sjtr4%3D 11024398 (Pubitemid 30748645)
19. AH Wu GJ Tsongalis 2001 Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases Am J Cardiol 87 1361 1366 10.1016/S0002-9149(01)01553-3 10.1016/S0002-9149(01)01553-3 1:CAS:528: DC%2BD3MXktVOjur4%3D 11397354 (Pubitemid 32523019)
20. J Frederiksen K Juul P Grande GB Jensen TV Schroeder A Tyjaerg, et al. 2004 Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the copenhagen city heart study Blood 104 3046 3051 10.1182/blood-2004-03-0897 10.1182/blood-2004- 03-0897 1:CAS:528:DC%2BD2cXhtVWhur%2FJ 15226189 (Pubitemid 39507118)
21. FR Rosendaal DS Siscovick SM Schwartz RK Beverly BM Psaty WT Longstreth, et al. 1997 Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women Blood 89 2817 2821 1:CAS:528:DyaK2sXisFCitrY%3D 9108400
22. JF Jewett 1976 Sickle cell trait, thalassemia, G6PD deficiency and puerper pulmonary embolism N Engl J Med 295 1076 1077 1:STN:280: DyaE2s%2FhtFKksQ%3D%3D 972663
23. DH Walker HK Hawkins P Hudson 1983 Fluminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency Arch Pathol Lab Med 107 121 125 1:STN:280: DyaL3s7lt1Wmtg%3D%3D 6687526